PMID- 23474361 OWN - NLM STAT- MEDLINE DCOM- 20131022 LR - 20130410 IS - 1557-3117 (Electronic) IS - 1053-2498 (Linking) VI - 32 IP - 5 DP - 2013 May TI - Left ventricular device implantation for advanced cardiac amyloidosis. PG - 563-8 LID - S1053-2498(13)01024-3 [pii] LID - 10.1016/j.healun.2013.01.987 [doi] AB - The purpose of this study was to analyze the post-hospital outcomes in patients with senile or familial cardiac amyloidosis treated with left ventricular assist device (LVAD) implantation. From December 1, 2008 to May 31, 2012, a total of 9 patients underwent LVAD placement for heart failure secondary to amyloidosis. Prior to LVAD placement, all patients were New York Heart Association (NYHA) Class IV and had a significantly decreased cardiac index (mean 1.93 liters/min/m(2) [1.64 to 2.36]). All patients tolerated LVAD implantation well. Post-operatively, 2 patients died prior to hospital discharge. Three patients died since discharge with a median survival of 13.7 months. Four patients remained alive with a follow-up of 16-24 months. The most common adverse event since placement has been gastrointestinal bleeding (3 of 9 patients). Firm conclusions cannot be drawn from our investigation, but the present observations suggest LVAD implantation is technically feasible for patients with severe heart failure due to advanced cardiac amyloidosis. CI - Copyright (c) 2013 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved. FAU - Swiecicki, Paul L AU - Swiecicki PL AD - Division of Hematology, Mayo Clinic, Rochester, Minnesota 55902, USA. FAU - Edwards, Brooks S AU - Edwards BS FAU - Kushwaha, Sudhir S AU - Kushwaha SS FAU - Dispenzieri, Angela AU - Dispenzieri A FAU - Park, Soon J AU - Park SJ FAU - Gertz, Morie A AU - Gertz MA LA - eng PT - Journal Article DEP - 20130306 PL - United States TA - J Heart Lung Transplant JT - The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation JID - 9102703 SB - IM MH - Aged MH - Amyloidosis/diagnosis/mortality/*therapy MH - Follow-Up Studies MH - Heart Diseases/diagnosis/mortality/*therapy MH - *Heart-Assist Devices MH - Humans MH - Male MH - Middle Aged MH - Prognosis MH - Retrospective Studies MH - Survival Rate MH - Treatment Outcome EDAT- 2013/03/12 06:00 MHDA- 2013/10/23 06:00 CRDT- 2013/03/12 06:00 PHST- 2012/07/21 00:00 [received] PHST- 2013/01/10 00:00 [revised] PHST- 2013/01/14 00:00 [accepted] PHST- 2013/03/12 06:00 [entrez] PHST- 2013/03/12 06:00 [pubmed] PHST- 2013/10/23 06:00 [medline] AID - S1053-2498(13)01024-3 [pii] AID - 10.1016/j.healun.2013.01.987 [doi] PST - ppublish SO - J Heart Lung Transplant. 2013 May;32(5):563-8. doi: 10.1016/j.healun.2013.01.987. Epub 2013 Mar 6.